Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14981467 | 1.00 | THRB (0.41) | THRBMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL16195225 | 0.98 | THRB (0.39) | THRBMEN1KMT2A | |
| SCHEMBL18049566 | 0.82 | — | — | |
| SCHEMBL16976716 | 0.82 | — | — | |
| SCHEMBL19876052 | 0.79 | — | — | |
| SCHEMBL29889012 | 0.79 | — | — | |
| SCHEMBL13618927 | 0.79 | — | — | |
| SCHEMBL13696003 | 0.79 | — | — | |
| SCHEMBL16095653 | 0.76 | — | — | |
| SCHEMBL14671356 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117624166-A | Triazole derivative and preparation method and application thereof | 苏州朗睿生物医药有限公司 | 2024-03-01 | — | — | CN | disclosed |
| US-9272260-B2 | Methods of synthesis and purification by use of a solid support | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) | 2016-03-01 | — | — | US | disclosed |
| US-20110077393-A1 | METHODS OF SYNTHESIS AND PURIFICATION BY USE OF A SOLID SUPPORT | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION (US) | 2011-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110077393-A1 | METHODS OF SYNTHESIS AND PURIFICATION BY USE OF A SOLID SUPPORT | WASF2, DCXR, RIOX2 | THRB 4834/4885MEN1 4605/4885KMT2A 2384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.